Impact of Anemia on Chemotherapy Efficacy and Prognosis in Patients with Advanced Non-small Cell Lung Cancer

Impact of Anemia on Chemotherapy Efficacy and Prognosis in Patients with Advanced Non-small Cell Lung Cancer

Background and objective Cancer-related anemia is the common complication of non-small cell lung cancer (NSCLC), which affects the quality of life (QOL), chemotherapy efficacy and prognosis in patients with NSCLC. In this study, we statistically analysed the incidence of anemia in NSCLC patients bef...

Full description

Bibliographic Details
Main Authors:	Chong'an XU, Yan GAO, Lin LI, Lili XING, Shu LIU
Format:	Article
Language:	zho
Published:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2010-10-01
Series:	Chinese Journal of Lung Cancer
Subjects:	Lung neoplasms Cancer-related anemia Chemotherapy efficacy Prognosis Quality of life
Online Access:	http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2010.10.07&path[]=2097

Similar Items

Clinical Significance of Serum Cytokeratin 19 Fragment in the Prediction of Chemotherapy Efficacy and Prognosis in Patients with Advanced Non-small Cell Lung Cancer
by: Chong'an XU, et al.
Published: (2010-10-01)

Correlation between Pre-treatment Anemia and Prognosis in Non-small Cell Lung Cancer Patients
by: Qiuhua DENG, et al.
Published: (2010-07-01)

Effects of EGFR Gene Polymorphisms on Efficacy and Prognosis  in Advanced Non-small Cell Lung Cancer Treated with EGFR-TKIs
by: Liangshan DA, et al.
Published: (2013-03-01)

Analysis of the relationship between the response after the First-line chemotherapy and the survival in the advanced non-small cell lung cancer
by: Liping LIN, et al.
Published: (2008-06-01)

Analysis of Correlation between TTF-1 and Sensitivity to First-line Chemotherapy and Prognosis in Patients with Small Cell Lung Cancer
by: Bingrui WANG, et al.
Published: (2020-07-01)

Long-term Efficacy of Radiofrequency Ablation Combined with Chemotherapy  in the Treatment of Patients with Advanced Non-small Cell Lung Cancer --A Retrospective Study
by: Shuhui DU, et al.
Published: (2017-10-01)

Comparison of the Efficacy and Safety of Icotinib with Standard Second-line  Chemotherapy in Previously Treated Advanced Non-small Cell Lung Cancer
by: Shuyang YAO, et al.
Published: (2015-06-01)

A Review on Pathological High-risk Factors and Postoperative Adjuvant Chemotherapy in Stage IA Lung Adenocarcinoma
by: Chen SHEN, et al.
Published: (2022-08-01)

Relationship between the Genetic Polymorphisms of Phase I and II Drug-metabolizing Enzymes, as well as the Outcome of Chemotherapy in Advanced Non-small Cell Lung Cancer
by: Weiying LI, et al.
Published: (2011-11-01)

Evaluation of Efficacy and Prognosis Analysis of Stage III-IV SMARCA4-deficient  Non-small Cell Lung Cancer Treated by PD-1 Immune Checkpoint Inhibitors plus  Chemotherapy and Chemotherapy
by: Xinjuan WANG, et al.
Published: (2023-09-01)

Efficacy of S-1 in Advanced Non-small Cell Lung Cancer Patients Treated  with More Than Two Lines of Chemotherapy
by: Yi YIN, et al.
Published: (2018-06-01)

Influencing factors of efficacy and long‐term use of amrubicin in patients with small cell lung cancer
by: Yutaka Takahara, et al.
Published: (2023-05-01)

Efficacy of Pemetrexed as Second-line Therapy or Beyond in Patients  with Advanced Non-small Cell Lung Cancer
by: Junling LI, et al.
Published: (2012-03-01)

Concurrent Chemoradiotherapy with Original Chemotherapy Regimens may not be Suitable for Patients Who Failed to Respond to Induction Chemotherapy in Limited-stage Small Cell Lung Cancer
by: Daquan WANG, et al.
Published: (2016-12-01)

The Role of Adjuvant Chemotherapy in Operable Non-small Cell Lung Cancer
by: Xiangtao YAN, et al.
Published: (2011-03-01)

Bevacizumab Combined with Chemotherapy for Advanced Non-small Cell Lung Cancer: A meta-analysis
by: Tao ZHANG, et al.
Published: (2013-02-01)

Clinical Investigation of Efficacy of Third-line and Beyond Pemetrexed Treatment in Advanced Non-squamous Non-small Cell Lung Cancer
by: Fei YU, et al.
Published: (2012-02-01)

Effect of the XRCC1 and XRCC3 Genetic Polymorphisms on the Efficacy of Platinum-based Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer
by: Chong’an XU, et al.
Published: (2011-12-01)

Assessment of chemotherapy-induced anemia in children with cancer
by: Ruggiero Antonio, et al.
Published: (2008-09-01)

Advance of second-line chemotherapy in advanced non-small cell lung cancer
by: Li ZHANG
Published: (2008-02-01)

Safety Analysis of Ambulatory Chemotherapy in Lung Cancer
by: Yun FENG, et al.
Published: (2010-07-01)

Advances in Hypoxia Microenvironment and Chemotherapy-resistant  of Lung Cancer
by: Yang GUO, et al.
Published: (2014-03-01)

Expression of TRIM59 in Non-small Cell Lung Cancer and Its Correlation with Prognosis
by: Haiying TIAN, et al.
Published: (2020-01-01)

Long-term Survival of A Patient with Advanced Non-small Cell Lung Cancer  on Bevacizumab Therapy: Case Report and Review of the Literature
by: Wei WU, et al.
Published: (2013-06-01)

Long-term Effect of Chemotherapy of Lung Cancer by Isolated Lung Perfusion and Planted Drug Pump on Pulmonary Artery
by: Chunfang ZHANG, , , , ,, et al.
Published: (2009-03-01)

A stable gene set for prediction of prognosis and efficacy of chemotherapy in gastric cancer
by: Rui Wu, et al.
Published: (2021-06-01)

Evaluation of Efficacy of Gefitinib on Advanced non-small-cell Lung Cancer (NSCLC) Resisted to Chemotherapy
by: Jiangjiang TU, et al.
Published: (2008-04-01)

Association between Polymorphisms of ERCC1 and Response in Patients with Advanced Non-small Cell Lung Cancer Receiving Cisplatin-based Chemotherapy
by: Yanfei GU, et al.
Published: (2010-04-01)

Peripheral Blood Laboratory Test Results Combined with TCF1+CD8+ T Lymphocytes  Ratio to Predict the Response and Prognosis of Immunotherapy to  Advanced Lung Cancer
by: Hong LUO, et al.
Published: (2023-08-01)

The pharmacoeconomic efficacy of chemotherapy for malignant neoplasms of the bronchus and lung
by: S. K. Yarovoy, et al.
Published: (2020-04-01)

Clinical Observation on the Target Therapy of Rh-Endostin, Combined with Chemotherapy in Advanced Non-Small Cell Lung Cancer
by: Yiling FENG, et al.
Published: (2009-07-01)

Clinical Observation of Erlotinib in the Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer
by: Haiqing YUAN, et al.
Published: (2009-07-01)

BSD2000 Deep Hyperthermia Combined with Chemotherapy of PT regimen in Patients with Non-small Cell Lung Cancer
by: Yanwen WANG, et al.
Published: (2010-02-01)

Progress of Postoperative Adjuvant Chemotherapy in Stage I Non-small Cell Lung Cancer
by: Bo LIU, et al.
Published: (2015-06-01)

Research Progress of Nutrition Support for Patients with Lung Cancer  During Chemotherapy
by: Yiqiao LUO, et al.
Published: (2014-12-01)

A Trial of the Safety and Efficacy of Chemotherapy Plus Anlotinib vs Chemotherapy Alone as Second- or Third-Line Salvage Treatment for Advanced Non-Small Cell Lung Cancer
by: Wang H, et al.
Published: (2020-05-01)

Role of RRM1 in the Treatment and Prognosis of Advanced Non-small Cell Lung Cancer
by: Jiawei TIAN, et al.
Published: (2015-06-01)

CT Guided Radiofrequency Ablation Followed Intratumoral Chemotherapy  in the Treatment of Early Stage Non-small Cell Lung Cancer
by: Weijian FENG, et al.
Published: (2016-05-01)

Clinical Effects for Patients with Recurrent Advanced Non-small Cell Lung Cancer Treated with Icotinib Hydrochloride
by: Jingying NONG, et al.
Published: (2013-05-01)

A Retrospective Analysis of Erlotinib and TP/GP Regimen in the Treatment of Advanced Non-small Cell Lung Cancer
by: Yongjuan WU, et al.
Published: (2009-12-01)